Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains - Journal of Thoracic Oncology

Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains - Journal of Thoracic Oncology

Hello Victor Norberto Cerasale Morteo Here are the latest recommendations for you. 1 Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains Li, Chenguang ... Chen, Haiquan Journal of Thoracic Oncology (2012)